Evidence map›Paper›PMID 42359930›Full record

ArticleAnalytical chemistry2026

High-Throughput Screening of Isomeric Reaction Products by Droplet Microfluidics Coupled to Cyclic Ion Mobility-Mass Spectrometry.

Laura I Penabad, Roger C Diehl, Aidan Olman, Maxwell J Unger, Tyler D Somerville, Juan C Vázquez López, Caitlin N Cain, Suman Chakrabarty, Lauren A M Murray, Michael R Armbruster and 5 more

Abstract read
In one paragraph

Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Laura I PenabadDepartment of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0003-3614-0956
Roger C DiehlLife Science Institute, University of Michigan, Ann Arbor, Michigan 48109, United States.
Aidan OlmanDepartment of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.
Maxwell J UngerDepartment of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0002-6081-8344
Tyler D SomervilleDepartment of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0009-0003-6125-6616
Juan C Vázquez LópezDepartment of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0009-0009-8728-4408
Caitlin N CainDepartment of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0001-8367-5799
Suman ChakrabartyLife Science Institute, University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0002-6611-3839
Lauren A M MurrayLife Science Institute, University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0003-3249-0828
Michael R ArmbrusterDepartment of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0002-9453-3419
Adriana Vargas FigueroaDepartment of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.
Ziqiao XuDepartment of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.
Brandon T RuotoloDepartment of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0002-6084-2328
Alison R H NarayanDepartment of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0001-8290-0077
Robert T KennedyDepartment of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0003-2447-7471

Funding

Microfluidic Systems to Enable Enzyme Engineering for Chemical SynthesisR01GM150948 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ROBERT T KENNEDY · 2023 to 2026
$1.3M
NIGMS NIH HHS R01 GM150948
6 · The paper itself

Abstract

Engineered biocatalysts enable highly selective chemical transformations with low environmental impact. Development of biocatalysts by directed evolution requires screening many enzyme variants for improved catalytic properties. The low throughput of commonly used label-free screening methods, e.g., liquid chromatography-mass spectrometry (LC-MS), becomes the rate-limiting step in biocatalyst development, limiting the coverage of protein sequence space explored. Direct MS methods have been applied to biocatalyst screening; however, these methods cannot be used to evaluate isomer selectivity. Ion mobility spectrometry is a separation technique readily combined with MS, facilitating isomer differentiation on the millisecond time scale. Here, we present a droplet microfluidic system coupled to cyclic ion mobility-mass spectrometry (cIM-MS) to enable the screening of isomeric products. The system was applied to the separation of biaryl benzofuran dimers formed by the fungal cytochrome P450 KtnC. The isomeric 5,7'-bibenzofuran and 7,7'-bibenzofuran products from KtnC variants were baseline-resolved within 32 ms by cIM. By infusing biocatalytic reaction mixtures as 5 nL droplets, an analysis throughput of 1.2 s/droplet was achieved using cIM-MS. Droplet cIM-MS was used to quantify standards in the reaction matrix with high agreement to actual concentrations of each isomer (i.e.,

Indexed as

High-Throughput Screening AssaysIon Mobility SpectrometryMass SpectrometryMicrofluidicsBiocatalysisCytochrome P-450 Enzyme SystemIsomerismCytochrome P-450 Enzyme System

Identifiers

PMID42359930
PMCPMC13624780

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.